COSTA MESA, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Rodedawg International Industries, Inc. (OTC:RWGI) is pleased to announce the appointment of new officers to lead its subsidiary, Elixicure, Inc.
Chris Swartz, CEO, states: "Last year, Rodedawg acquired Elixicure's assets of brands, manufacturing equipment, trade secrets, and online stores. According to Future market Insights research, as the world continues to face chronic pain disorder burden, efficient and relieving topical pain relief becomes paramount for managing this condition. Given this, global demand for topical pain relief is anticipated to surge at a 5.6% CAGR through 2034. The market value is projected to increase from US$ 11 billion in 2024 to US$ 19 billion by 2034. The market was valued at US$ 10 billion in 2023 and is anticipated to exhibit a Y-o-Y growth of 5.2% in 2024. With this kind of growth and opportunity, the Company is now ready to rapidly expand Elixicure." Effective immediately, the following executives will assume key roles:
*Jeff Byrne joins as the new Head of Operations for Elixicure, Inc. With a proven track record in operational management, Jeff will be instrumental in driving efficiency and excellence in Elixicure's day-to-day functions.
*Don Dedo assumes the responsibility of overseeing online sales, affiliates sales, and international sales for Elixicure, Inc. His extensive experience in sales and marketing will be pivotal in expanding Elixicure's reach and market presence.
These appointments reflect Rodedawg Ind. Intl., Inc.'s commitment to strengthening its leadership team and positioning Elixicure, Inc. for continued growth and success in the topical pain relief industry.
"We are thrilled to welcome Jeff Byrne and Don Dedo to lead Elixicure, Inc. Their leadership and expertise will play a vital role in driving ...